Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck scraps development of osteoporosis drug due to stroke risk
Merck scraps development of osteoporosis drug due to stroke risk
Merck scraps development of osteoporosis drug due to stroke risk
Submitted by
admin
on September 2, 2016 - 9:47am
Source:
Yahoo/Reuters
News Tags:
Merck
osteoporosis
stroke
Odanacatib
Headline:
Merck scraps development of osteoporosis drug due to stroke risk
Do Not Allow Advertisers to Use My Personal information
